CIGB-258, a Potential Novel Approach to Treat Sepsis-like Hyperinflammation, Reduces Gastrointestinal Hemorrhage in Zebrafish Exposed to Carboxymethyllysine and Ethanol

<b>Objective:</b> CIGB-258 is a 3 KDa altered peptide ligand recognized for its anti-inflammatory activity. Herein, the effect of CIGB-258 was assessed against carboxymethyllysine (CML) and ethanol (Et-OH)-induced sepsis-like events in zebrafish (<i>Danio rerio</i>). <b>Methodology:</b> Adult zebraf...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kyung-Hyun Cho, Yunki Lee, Sang Hyuk Lee, Ashutosh Bahuguna, María del Carmen Domínguez-Horta, Gillian Martínez-Donato
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-03-01
Edice:	Pharmaceuticals
Témata:	CIGB-258 (Jusvinza<sup>®</sup>) carboxymethyllysine inflammation intestine interleukin-6 oxidative stress
On-line přístup:	https://www.mdpi.com/1424-8247/19/3/510
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!